Use of insulin-like growth factors I and II for inhibition of in

Details Use of insulin-like growth factors I and II for inhibition of in Use of insulin-like growth factors I and II for inhibition of in

1997-05-16

1998-12-01

Tsang, Cecilia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 3, 514 4, 514 21, A61K 3800, A61K 3726, C07K 710

Patent

active

058438998

ABSTRACT:
The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection.

REFERENCES:
patent: 4738921 (1988-04-01), Belagaje et al.
patent: 4783524 (1988-11-01), Larsen et al.
patent: 4837148 (1989-06-01), Cregg
patent: 4861757 (1989-08-01), Antoniades et al.
patent: 4929555 (1990-05-01), Cregg et al.
patent: 4988675 (1991-01-01), Froesch et al.
patent: 5028531 (1991-07-01), Ueda et al.
patent: 5106832 (1992-04-01), Froesch et al.
patent: 5158875 (1992-10-01), Miller et al.
patent: 5187151 (1993-02-01), Clark et al.
patent: 5206023 (1993-04-01), Hunziker
patent: 5270300 (1993-12-01), Hunziker
patent: 5294446 (1994-03-01), Schlameus et al.
Shoskes and Halloran, TransPlantation Proceedings vol. 23 No. 1 (Feb.) 1991, pp. 599-601.
Schalkwijk et al. Arthritis and Rheumatism, vol. 32, No. 7 (894-900) (1989).
Gluckman, Biochem. Biophys. Res. Comm. 182:593 (1992).
Zimmerman et al. Gastroenterology :105(2) pp. 399-409 (1993) Abstract.
Chirgwin, Biochemistry, (1979) 18:5294.
Cockfield, J Immunol, (1989) 142:1120.
Cregg, Mol. Cell. Biol., (1985) 5:3376.
Das, J. Bacteriol., (1984) 158:1165.
De Louvencourt, J. Bacteriol., (1983) 154:737.
Graham, J. Gen. Virol., (1977) 36:59.
Ito, J. Bacteriol., (1983) 153:163.
Kurtz, Mol. Cell. Biol., (1986) 6:142.
Mather, Biol. Reprod., (1980) 23:243.
Phillips, New Engl. J. Med., (1980) 302:371-380.
Reyes., Nature, (1982) 297:598.
Roggenkamp, Mol. Gen. Genet., (1986) 202:302.
Salacinski, Anal Biochem, (1981) 117:136.
Shoskes, Transplantation, (1990) 49:201.
Shoskes, Transplant Proc, (1991) 23:599.
Tilburn, Gene, (1983) 2:205.
Urlaub, PNAS (USA), (1980) 77:4216.
Van den Berg, Bio/Technology, (1990) 8:135.
Yelton, PNAS (USA), (1984) 1981:1470.
Kelly et al., EMBO J., (1985) 4:475-479.
Feinberg and Volgelstein, Anal Biochem, (1983) 132:6.
Gaillardin, Curr. Genet., (1985) 10:49.
Geraughty, Curr. Opin. Immunol., (1993) 5:3.
Gleeson, J. Gen. Microbiol., (1986) 32:3459.
Glisin, Biochemistry, (1974) 13:2633.
Gray, PNAS (USA) (1983) 80:5842.
Miller, PNAS (USA) (1992) 89:11876.
Matejka, Kidney International (1992) 42:1113.
Gluckman, Biochem. Biophys. Res. Comm. (1992) 182:593.
Middleton, Annals of Rheumatic Diseases (1992) 51:440.
Moskowitz, J. of Rheumatology, supp. (1991) 27:147.
Dequeker Arthritis and Rheumatism (1993) 36:1702.
Hampton, J. of Biol. Chem. (1989) 264:19155.
Denko, J. of Rheumatology (1990) 17:1217.
Ballance, Biochem. Biophys. Res. Comm., (1983) 112:284.
Barr, Bio/Technology, (1987) 5:486.
Beach, Nature, (1981) 300:706.
Beier, Nature, (1982) 300:724.
Brake, PNAS (USA), (1984) 81:4642.
Buergisser, Biochem. Biophys. Res. Comm. (1990) 169:832-839.
Nolan et al., Cell Regulation, (1990) 1:197-213.
Ding J. of Clin. Invest. (1993) 91:2281.
Hinnen, PNAS (USA), (1978) 75:1929.
Li, PNAS, (1983) 80:2216-2220.
Rinderknecht, J Biol Chem, (1978) 253:2769.
Rinderknecht, FEBS Letters, (1978) 89:283.
Rogachefsky, Osteoarthritis and Cartilage, (1993) 1:105-114.
Urdea, PNAS (USA), (1983) 80:7461.
Wells, Gene (1985) 34:315.

Affiliated with

Also associated with

Rating

Use of insulin-like growth factors I and II for inhibition of in does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of insulin-like growth factors I and II for inhibition of in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin-like growth factors I and II for inhibition of in will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2395659